FAQs About PerkinElmer Labs' Preeclampsia Screening Tests
Last month, we posted a lengthy article, Screening Tests for Preeclampsia, about a new preeclampsia screening test available in the US. On August 14, a press release from PerkinElmer announced the launch of its new screening test for early onset preeclampsia, Preeclampsia Screen™ | T1. This month we posed five of the most frequently asked patient questions to company officials. Here are their responses:
How much will the screening test cost?
The list price of the test is $495. This will be billed to a patient's insurance, if available. If the test is not covered by a patient's insurance and the patient takes advantage of applicable payment options, they can expect to spend approximately $200 out of pocket for the test.
Will my insurance cover it?
This is uncertain, at this time, as the screening test just launched on August 1, 2013. It is our plan to submit to insurances and work with them on reimbursement for these new claims.
Will it be available everywhere in the U.S., and can any doctor or midwife order it for me?
It must be ordered by a qualified health care provider who is able to order laboratory tests and who has set up an account with PerkinElmer Labs/NTD. It is available to all qualified healthcare providers in the country.
Is it available outside the US?
Yes. Samples can be received at PerkinElmer Labs/NTD from outside the U.S., as long as they conform to all sample and shipping requirements, including any international regulations.
Will the screening test tell me when I might start getting sick, if I'm going to get preeclampsia?
The test will not tell you or your healthcare provider when you may begin having symptoms of preeclampsia. What it can tell your healthcare provider is whether or not you are at increased risk of developing early onset preeclampsia, which is preeclampsia that results in the delivery of the fetus before 34 weeks gestation.
Related Articles
Your story is needed to improve outcomes for moms like you. Add your voice to critical preeclampsia research to ensure that every story is heard.
Frequently asked questions about the Preeclampsia Registry, a patient-driven registry and biobank.
The Preeclampsia Foundation offers research funding, study recruitment, and other patient engagement services to researchers.
We provide research grant funding to advance progress towards detection, prevention, or treatment of preeclampsia, HELLP syndrome, and other hypertensive disorders of pregnancy.
Preeclampsia Foundation and Preeclampsia Foundation Canada announced that applications are now being accepted for the 2026 Vision Grant research funding program. Three of the four grants focus on heal...
How does preeclampsia affect health after pregnancy? Preeclampsia doesn’t always end with delivery. It is now recognized as an early warning sign for future cardiovascular disease. Women who h...
Recent findings in preeclampsia research have shown that preeclampsia likely has at least two variants – an early onset and a late onset variant. Early onset is typically defined as before 34 we...
Preeclampsia is a pregnancy complication marked by new-onset high blood pressure and signs of stress on organs such as the kidneys, liver, and brain. While much attention is often given to preterm dis...
Preeclampsia is a serious problem that can happen during pregnancy. It often affects the brain and can cause headaches, vision problems, strong reflexes, and seizures (called eclampsia). In this study...